Filip Dubovsky
Equibles does not estimate personal net worth.
About Filip Dubovsky
Novavax Inc reported in an 8-K filed May 23, 2024 that Filip Dubovsky retired as President, Research and Development, effective June 30, 2024. The proxy statement of Novavax Inc reports total compensation of $1,554,368 for Filip Dubovsky in fiscal 2024, including a base salary of $336,254. Disclosed compensation is on record for 2 fiscal years.
“On May 20, 2024, Filip Dubovsky notified Novavax, Inc. (the "Company") of his decision to retire as President, Research and Development, effective as of June 30, 2024.”
Affiliation history
-
Novavax Inc (NVAX)
Source not stated
Start not stated–2024-06-30
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Novavax Inc (NVAX) | Former President, Research & Development | $336,254 | $1,554,368 |
| 2023 | Novavax Inc (NVAX) | Former President, Research & Development | $659,200 | $1,934,392 |